Cargando…

Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options

Detalles Bibliográficos
Autores principales:	Hermsen, Mario A., Bossi, Paolo, Franchi, Alessandro, Lechner, Matt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046049/ https://www.ncbi.nlm.nih.gov/pubmed/36980561 http://dx.doi.org/10.3390/cancers15061675

Ejemplares similares

Molecular Basis and Rationale for the Use of Targeted Agents and Immunotherapy in Sinonasal Cancers
por: Esposito, Andrea, et al.
Publicado: (2022)

Personalized Medicine in Skull Base and Sinonasal Tumors
por: Mattavelli, Davide, et al.
Publicado: (2022)

Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities
por: Taverna, Cecilia, et al.
Publicado: (2022)

Genetic profiling of poorly differentiated sinonasal tumours
por: López-Hernández, Alejandro, et al.
Publicado: (2018)

Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors
por: Villanueva-Fernández, Eva, et al.
Publicado: (2022)

Sinonasal cancers treatments: state of the art
por: Ferrari, Marco, et al.
Publicado: (2021)

Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside
por: Lechner, Matt, et al.
Publicado: (2020)

DNA methylation-based classification of sinonasal tumors
por: Jurmeister, Philipp, et al.
Publicado: (2022)

EGFR mutations in sinonasal squamous tumors: oncogenic and therapeutic implications
por: Udager, Aaron M., et al.
Publicado: (2015)

Does Reorganization of Clinicopathological Information Improve Prognostic Stratification and Prediction of Chemoradiosensitivity in Sinonasal Carcinomas? A Retrospective Study on 145 Patients
por: Ferrari, Marco, et al.
Publicado: (2022)

Prognostic and Therapeutic Implications of Immune Classification by CD8(+) Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Sinonasal Squamous Cell Carcinoma
por: García-Marín, Rocío, et al.
Publicado: (2021)

EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma
por: Pacini, Laura, et al.
Publicado: (2022)

Signaling Pathways mTOR and ERK as Therapeutic Targets in Sinonasal Intestinal-Type Adenocarcinoma
por: Codina-Martínez, Helena, et al.
Publicado: (2023)

Benign Lesions in Mucosa Adjacent to Intestinal-Type Sinonasal Adenocarcinoma
por: Vivanco, Blanca, et al.
Publicado: (2011)

Morpho-Molecular Assessment Indicates New Prognostic Aspects and Personalized Therapeutic Options in Sinonasal Melanoma
por: Freiberger, Sandra N., et al.
Publicado: (2019)

Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors
por: Hieggelke, Lena, et al.
Publicado: (2021)

Curl pattern classification: A potential tool for communication and risk stratification
por: Krueger, Loren, et al.
Publicado: (2022)

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
por: Li, Jianbin, et al.
Publicado: (2022)

Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma
por: Riobello, Cristina, et al.
Publicado: (2021)

The next age of immunotherapy: optimisation, stratification and therapeutic synergies
por: Halama, Niels
Publicado: (2018)

Sinonasal teratocarcinosarcoma: a therapeutic dilemma
por: Peralta Suarez, Geraldine, et al.
Publicado: (2022)

Biphenotypic sinonasal sarcoma: European multicentre case-series and systematic literature review
por: Turri-Zanoni, Mario, et al.
Publicado: (2022)

Sinonasal Adenocarcinoma: Update on Classification, Immunophenotype and Molecular Features
por: Leivo, Ilmo
Publicado: (2016)

Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment
por: Turri-Zanoni, Mario, et al.
Publicado: (2022)

Mesenchymal Stromal Cells: From Therapeutic Option to Therapeutic Target
por: Stefani, Francesca Romana, et al.
Publicado: (2023)

Genetic understanding of vascular anomalies: better classification and risk‐stratification with targeted therapeutic options – a new horizon for vascular anomaly patients
por: van der Vleuten, C.J.M.
Publicado: (2022)

Sinonasal Squamous Cell Carcinoma, a Narrative Reappraisal of the Current Evidence
por: Ferrari, Marco, et al.
Publicado: (2021)

New therapeutic options opened by the molecular classification of gastric cancer
por: Chivu-Economescu, Mihaela, et al.
Publicado: (2018)

Nandrolone decanoate: new therapeutic option for telomeropathies?
por: Frieri, Camilla
Publicado: (2023)

Hemorrhagic stroke—Pathomechanisms of injury and therapeutic options
por: Chaudhary, Neeraj, et al.
Publicado: (2019)

Leprosy stigma & the relevance of emergent therapeutic options
por: Sardana, Kabir, et al.
Publicado: (2020)

The Use of Epigenetic Biomarkers as Diagnostic and Therapeutic Options
por: Zhang, Le, et al.
Publicado: (2022)

New insights into classification and risk stratification of encapsulated thyroid tumors with a predominantly papillary architecture
por: Jung, Chan Kwon, et al.
Publicado: (2020)

Exploring the implications of HPV infection for head and neck cancer
por: Field, Nigel, et al.
Publicado: (2015)

Development of cancer metabolism as a therapeutic target: new pathways, patient studies, stratification and combination therapy
por: Harris, Adrian L.
Publicado: (2019)

Sinonasal hemangiopericytoma: A rare sinonasal tumor
por: Pokharel, Apar, et al.
Publicado: (2023)

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
por: Menyhárt, Otília, et al.
Publicado: (2020)

Leveraging MYC as a therapeutic treatment option for TNBC
por: Carey, Jason P.W., et al.
Publicado: (2018)

Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension
por: Kim, Hyung Yoon, et al.
Publicado: (2019)

Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options
por: Donnez, Jacques, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n4eavvtcfp5o3ll0ftdgbusb52